0 XP   0   0   0

Cresco Labs Inc
Buy, Hold or Sell?

I guess you are interested in Cresco Labs Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Cresco Labs Inc

Let's start. I'm going to help you getting a better view of Cresco Labs Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Cresco Labs Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Cresco Labs Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Cresco Labs Inc. The closing price on 2022-10-03 was $2.7997 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Cresco Labs Inc Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

1.1. Profitability of Cresco Labs Inc.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Cresco Labs Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cresco Labs Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Net Profit Margin of -6.2% means that $[indicator name=netProfitMargin&period=MRQ&percentage=1 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cresco Labs Inc:

  • The MRQ is -6.2%. The company is making a loss. -1
  • The TTM is -37.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-6.2%TTM-37.8%+31.6%
TTM-37.8%YOY-13.0%-24.9%
TTM-37.8%5Y-19.0%-18.8%
5Y-19.0%10Y-19.0%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.2%-0.9%-5.3%
TTM-37.8%0.3%-38.1%
YOY-13.0%0.1%-13.1%
5Y-19.0%-0.9%-18.1%
10Y-19.0%-0.3%-18.7%
1.1.2. Return on Assets

Shows how efficient Cresco Labs Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cresco Labs Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • -0.8% Return on Assets means that Cresco Labs Inc generated $-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cresco Labs Inc:

  • The MRQ is -0.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -5.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.8%TTM-5.1%+4.3%
TTM-5.1%YOY-1.7%-3.4%
TTM-5.1%5Y-2.0%-3.1%
5Y-2.0%10Y-2.0%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.8%0.1%-0.9%
TTM-5.1%0.1%-5.2%
YOY-1.7%-0.1%-1.6%
5Y-2.0%-0.2%-1.8%
10Y-2.0%-0.1%-1.9%
1.1.3. Return on Equity

Shows how efficient Cresco Labs Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cresco Labs Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • -1.7% Return on Equity means Cresco Labs Inc generated $-0.02 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cresco Labs Inc:

  • The MRQ is -1.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -11.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.7%TTM-11.9%+10.2%
TTM-11.9%YOY-3.7%-8.2%
TTM-11.9%5Y-5.0%-6.9%
5Y-5.0%10Y-5.0%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.7%0.6%-2.3%
TTM-11.9%0.4%-12.3%
YOY-3.7%0.4%-4.1%
5Y-5.0%-0.3%-4.7%
10Y-5.0%0.1%-5.1%

1.2. Operating Efficiency of Cresco Labs Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Cresco Labs Inc is operating .

  • Measures how much profit Cresco Labs Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cresco Labs Inc to the Drug Manufacturers-Specialty & Generic industry mean.
  • An Operating Margin of 11.2% means the company generated $0.11  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cresco Labs Inc:

  • The MRQ is 11.2%. The company is operating less efficient.
  • The TTM is 13.5%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ11.2%TTM13.5%-2.3%
TTM13.5%YOY15.9%-2.4%
TTM13.5%5Y8.4%+5.1%
5Y8.4%10Y8.4%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ11.2%2.5%+8.7%
TTM13.5%1.6%+11.9%
YOY15.9%2.7%+13.2%
5Y8.4%2.0%+6.4%
10Y8.4%1.3%+7.1%
1.2.2. Operating Ratio

Measures how efficient Cresco Labs Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 1.38 means that the operating costs are $1.38 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Cresco Labs Inc:

  • The MRQ is 1.379. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.378. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.379TTM1.378+0.001
TTM1.378YOY1.342+0.036
TTM1.3785Y1.363+0.015
5Y1.36310Y1.3630.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3791.497-0.118
TTM1.3781.446-0.068
YOY1.3421.389-0.047
5Y1.3631.370-0.007
10Y1.3631.182+0.181

1.3. Liquidity of Cresco Labs Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Cresco Labs Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 1.38 means the company has $1.38 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Cresco Labs Inc:

  • The MRQ is 1.377. The company is just able to pay all its short-term debts.
  • The TTM is 1.548. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.377TTM1.548-0.171
TTM1.548YOY1.451+0.098
TTM1.5485Y3.444-1.896
5Y3.44410Y3.4440.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3771.902-0.525
TTM1.5481.908-0.360
YOY1.4512.112-0.661
5Y3.4442.173+1.271
10Y3.4441.891+1.553
1.3.2. Quick Ratio

Measures if Cresco Labs Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean)
  • A Quick Ratio of 0.20 means the company can pay off $0.20 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cresco Labs Inc:

  • The MRQ is 0.195. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.184. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.195TTM0.184+0.011
TTM0.184YOY0.164+0.020
TTM0.1845Y0.208-0.024
5Y0.20810Y0.2080.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1950.667-0.472
TTM0.1840.792-0.608
YOY0.1640.819-0.655
5Y0.2080.838-0.630
10Y0.2080.823-0.615

1.4. Solvency of Cresco Labs Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Cresco Labs Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Debt to Asset Ratio of 0.54 means that Cresco Labs Inc assets are financed with 53.9% credit (debt) and the remaining percentage (100% - 53.9%) is financed by its owners/shareholders. -6.2%

Let's take a look of the Debt to Asset Ratio trends of Cresco Labs Inc:

  • The MRQ is 0.539. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.547. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.539TTM0.547-0.008
TTM0.547YOY0.438+0.109
TTM0.5475Y0.342+0.205
5Y0.34210Y0.3420.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5390.433+0.106
TTM0.5470.425+0.122
YOY0.4380.396+0.042
5Y0.3420.402-0.060
10Y0.3420.404-0.062
1.4.2. Debt to Equity Ratio

Measures if Cresco Labs Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Debt to Equity ratio of 114.7% means that company has $1.15 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cresco Labs Inc:

  • The MRQ is 1.147. The company is able to pay all its debts with equity. +1
  • The TTM is 1.257. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.147TTM1.257-0.110
TTM1.257YOY0.927+0.330
TTM1.2575Y0.798+0.459
5Y0.79810Y0.7980.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1470.668+0.479
TTM1.2570.677+0.580
YOY0.9270.624+0.303
5Y0.7980.686+0.112
10Y0.7980.705+0.093

2. Market Valuation of Cresco Labs Inc

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Cresco Labs Inc.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of -2.11 means the investor is paying $-2.11 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cresco Labs Inc:

  • The EOD is -2.358. Company is losing money. -2
  • The MRQ is -2.106. Company is losing money. -2
  • The TTM is -4.955. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-2.358MRQ-2.106-0.252
MRQ-2.106TTM-4.955+2.849
TTM-4.955YOY-24.576+19.621
TTM-4.9555Y-18.302+13.347
5Y-18.30210Y-18.3020.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-2.358-0.010-2.348
MRQ-2.106-0.067-2.039
TTM-4.955-0.006-4.949
YOY-24.576-0.031-24.545
5Y-18.3023.518-21.820
10Y-18.3024.263-22.565
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Cresco Labs Inc.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Cresco Labs Inc:

  • The MRQ is -0.010. Very Bad. -2
  • The TTM is -0.024. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-0.010TTM-0.024+0.014
TTM-0.024YOY3.631-3.656
TTM-0.0245Y1.275-1.300
5Y1.27510Y1.2750.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.0100.003-0.013
TTM-0.0240.019-0.043
YOY3.6310.024+3.607
5Y1.2750.023+1.252
10Y1.2750.026+1.249

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Cresco Labs Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A PB ratio of 0.95 means the investor is paying $0.95 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Cresco Labs Inc:

  • The EOD is 1.068. Good. +1
  • The MRQ is 0.954. Very good. +2
  • The TTM is 2.219. Good. +1
Trends
Current periodCompared to+/- 
EOD1.068MRQ0.954+0.114
MRQ0.954TTM2.219-1.265
TTM2.219YOY3.022-0.803
TTM2.2195Y1.429+0.789
5Y1.42910Y1.4290.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD1.0681.407-0.339
MRQ0.9541.588-0.634
TTM2.2192.019+0.200
YOY3.0222.258+0.764
5Y1.4291.986-0.557
10Y1.4291.531-0.102

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Cresco Labs Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--2.6212.762-5%3.341-22%1.894+38%1.894+38%
Book Value Per Share Growth---0.291-0.288-1%0.055-629%0.238-222%0.238-222%
Current Ratio--1.3771.548-11%1.451-5%3.444-60%3.444-60%
Debt To Asset Ratio--0.5390.547-1%0.438+23%0.342+58%0.342+58%
Debt To Equity Ratio--1.1471.257-9%0.927+24%0.798+44%0.798+44%
Dividend Per Share----0%-0%-0%-0%
Eps---0.045-0.297+555%-0.098+116%-0.123+172%-0.123+172%
Eps Growth--203.916206.585-1%14.161+1340%115.080+77%115.080+77%
Gains Per Share---0.291-0.288-1%0.055-629%0.238-222%0.238-222%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin---0.062-0.378+510%-0.130+109%-0.190+207%-0.190+207%
Operating Margin--0.1120.135-17%0.159-30%0.084+33%0.084+33%
Operating Ratio--1.3791.378+0%1.342+3%1.363+1%1.363+1%
Pb Ratio1.068+11%0.9542.219-57%3.022-68%1.429-33%1.429-33%
Pe Ratio-2.358-12%-2.106-4.955+135%-24.576+1067%-18.302+769%-18.302+769%
Peg Ratio---0.010-0.024+137%3.631-100%1.275-101%1.275-101%
Price Per Share2.800+11%2.5006.114-59%9.940-75%6.242-60%6.242-60%
Quick Ratio--0.1950.184+6%0.164+19%0.208-6%0.208-6%
Return On Assets---0.008-0.051+541%-0.017+108%-0.020+151%-0.020+151%
Return On Equity---0.017-0.119+603%-0.037+121%-0.050+193%-0.050+193%
 EOD+1 -2MRQTTM+9 -9YOY+9 -95Y+10 -810Y+10 -8

3.2. Fundamental Score

Let's check the fundamental score of Cresco Labs Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.358
Price to Book Ratio (EOD)Between0-11.068
Net Profit Margin (MRQ)Greater than0-0.062
Operating Margin (MRQ)Greater than00.112
Quick Ratio (MRQ)Greater than10.195
Current Ratio (MRQ)Greater than11.377
Debt to Asset Ratio (MRQ)Less than10.539
Debt to Equity Ratio (MRQ)Less than11.147
Return on Equity (MRQ)Greater than0.15-0.017
Return on Assets (MRQ)Greater than0.05-0.008
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Cresco Labs Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.230
Ma 20Greater thanMa 503.161
Ma 50Greater thanMa 1003.481
Ma 100Greater thanMa 2003.418
OpenGreater thanClose2.910
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets1,701,043
Total Liabilities917,419
Total Stockholder Equity799,549
 As reported
Total Liabilities 917,419
Total Stockholder Equity+ 799,549
Total Assets = 1,701,043

Assets

Total Assets1,701,043
Total Current Assets314,317
Long-term Assets314,317
Total Current Assets
Cash And Cash Equivalents 89,508
Net Receivables 44,592
Inventory 158,912
Other Current Assets 21,305
Total Current Assets  (as reported)314,317
Total Current Assets  (calculated)314,317
+/-0
Long-term Assets
Property Plant Equipment 487,481
Goodwill 448,376
Long Term Investments 1,992
Intangible Assets 433,345
Other Assets 11,776
Long-term Assets  (as reported)1,386,726
Long-term Assets  (calculated)1,382,970
+/- 3,756

Liabilities & Shareholders' Equity

Total Current Liabilities228,216
Long-term Liabilities689,203
Total Stockholder Equity799,549
Total Current Liabilities
Short Long Term Debt 19,357
Accounts payable 36,988
Other Current Liabilities 103,819
Total Current Liabilities  (as reported)228,216
Total Current Liabilities  (calculated)160,164
+/- 68,052
Long-term Liabilities
Long term Debt 467,082
Capital Lease Obligations Min Short Term Debt146,115
Other Liabilities 98,125
Long-term Liabilities Other 7,008
Long-term Liabilities  (as reported)689,203
Long-term Liabilities  (calculated)718,330
+/- 29,127
Total Stockholder Equity
Common Stock1,700,008
Retained Earnings -900,031
Other Stockholders Equity -428
Total Stockholder Equity (as reported)799,549
Total Stockholder Equity (calculated)799,549
+/-0
Other
Capital Stock1,700,008
Common Stock Shares Outstanding 298,926
Net Debt 396,931
Net Invested Capital 1,285,988
Net Tangible Assets -85,928
Net Working Capital 86,101



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
> Total Assets 
0
74,465
149,461
318,111
364,044
355,032
416,526
616,554
1,157,028
1,209,104
1,206,649
1,333,124
1,407,132
1,595,411
1,569,938
1,780,463
0
1,701,043
1,701,04301,780,4631,569,9381,595,4111,407,1321,333,1241,206,6491,209,1041,157,028616,554416,526355,032364,044318,111149,46174,4650
   > Total Current Assets 
0
45,620
112,596
192,704
183,367
160,184
190,303
159,338
216,249
256,726
257,094
361,754
381,692
293,744
449,048
421,755
399,800
314,317
314,317399,800421,755449,048293,744381,692361,754257,094256,726216,249159,338190,303160,184183,367192,704112,59645,6200
       Cash And Cash Equivalents 
0
31,699
93,916
131,302
106,090
61,125
73,658
49,102
68,581
70,994
57,689
136,339
255,503
131,040
252,838
223,543
0
89,508
89,5080223,543252,838131,040255,503136,33957,68970,99468,58149,10273,65861,125106,090131,30293,91631,6990
       Net Receivables 
0
2,301
2,897
11,384
5,334
8,305
14,087
17,099
17,354
19,289
30,249
31,704
38,568
45,053
50,300
44,691
48,691
44,592
44,59248,69144,69150,30045,05338,56831,70430,24919,28917,35417,09914,0878,3055,33411,3842,8972,3010
       Other Current Assets 
0
5,576
8,036
25,497
16,327
1,809
3,376
43,582
49,143
66,224
61,311
57,106
12,292
14,720
14,381
16,878
15,357
21,305
21,30515,35716,87814,38114,72012,29257,10661,31166,22449,14343,5823,3761,80916,32725,4978,0365,5760
   > Long-term Assets 
0
0
0
0
180,677
194,848
226,223
457,216
940,779
952,378
949,555
971,370
1,025,440
1,301,667
1,120,890
1,358,708
0
1,386,726
1,386,72601,358,7081,120,8901,301,6671,025,440971,370949,555952,378940,779457,216226,223194,848180,6770000
       Property Plant Equipment 
0
16,780
23,572
39,721
94,689
107,190
129,021
202,292
262,687
268,528
265,688
283,638
313,036
373,852
419,698
452,888
480,647
487,481
487,481480,647452,888419,698373,852313,036283,638265,688268,528262,687202,292129,021107,19094,68939,72123,57216,7800
       Goodwill 
0
0
0
51,146
51,146
51,159
51,159
137,719
458,041
451,632
451,632
451,861
459,701
564,210
395,878
446,767
0
448,376
448,3760446,767395,878564,210459,701451,861451,632451,632458,041137,71951,15951,15951,14651,146000
       Long Term Investments 
0
7,306
8,362
433
440
426
4,445
1,278
4,682
5,079
5,102
4,360
11,137
9,378
6,438
5,912
0
1,992
1,99205,9126,4389,37811,1374,3605,1025,0794,6821,2784,4454264404338,3627,3060
       Intangible Assets 
0
3,406
3,577
25,464
24,958
25,448
26,850
94,206
192,755
199,882
195,953
195,518
215,249
335,460
269,451
437,644
0
433,345
433,3450437,644269,451335,460215,249195,518195,953199,882192,75594,20626,85025,44824,95825,4643,5773,4060
       Other Assets 
0
1,354
1,354
8,643
9,444
10,046
14,748
21,478
22,218
26,911
27,441
32,231
22,253
14,796
25,164
11,276
11,439
11,776
11,77611,43911,27625,16414,79622,25332,23127,44126,91122,21821,47814,74810,0469,4448,6431,3541,3540
> Total Liabilities 
0
7,254
9,313
35,130
86,717
82,655
101,275
293,931
417,320
472,286
465,025
608,366
696,751
664,783
857,655
982,727
0
917,419
917,4190982,727857,655664,783696,751608,366465,025472,286417,320293,931101,27582,65586,71735,1309,3137,2540
   > Total Current Liabilities 
0
5,360
7,271
25,230
37,029
31,500
45,746
150,169
141,190
163,396
243,731
194,640
276,612
194,646
209,235
288,394
331,194
228,216
228,216331,194288,394209,235194,646276,612194,640243,731163,396141,190150,16945,74631,50037,02925,2307,2715,3600
       Short-term Debt 
0
188
0
0
339
9
3
0
0
0
0
0
0
0
0
0
0
0
0000000000039339001880
       Short Long Term Debt 
0
188
0
0
339
9
3
0
20,787
23,922
111,532
15,046
28,014
28,056
15,445
19,928
0
19,357
19,357019,92815,44528,05628,01415,046111,53223,92220,787039339001880
       Accounts payable 
0
2,804
5,038
4,430
7,378
10,879
12,116
32,463
35,251
38,324
28,808
26,170
36,999
21,985
25,617
32,278
33,285
36,988
36,98833,28532,27825,61721,98536,99926,17028,80838,32435,25132,46312,11610,8797,3784,4305,0382,8040
       Other Current Liabilities 
0
1,513
1,523
17,910
178
178
178
75,771
45,423
47,676
46,886
70,286
85,785
47,220
80,446
119,954
151,608
103,819
103,819151,608119,95480,44647,22085,78570,28646,88647,67645,42375,77117817817817,9101,5231,5130
   > Long-term Liabilities 
0
0
0
0
49,688
51,155
55,529
143,762
276,130
308,890
221,294
413,726
420,139
470,137
648,420
694,333
0
689,203
689,2030694,333648,420470,137420,139413,726221,294308,890276,130143,76255,52951,15549,6880000
       Other Liabilities 
0
1,894
2,042
9,900
5,920
7,203
11,603
60,356
63,794
73,330
78,724
98,931
85,132
102,924
79,209
110,318
99,818
98,125
98,12599,818110,31879,209102,92485,13298,93178,72473,33063,79460,35611,6037,2035,9209,9002,0421,8940
> Total Stockholder Equity
21,678
49,150
139,238
121,031
118,284
116,275
162,310
187,082
610,123
595,023
611,827
574,446
612,400
882,782
670,375
755,554
0
799,549
799,5490755,554670,375882,782612,400574,446611,827595,023610,123187,082162,310116,275118,284121,031139,23849,15021,678
   Common Stock
0
63,004
150,214
142,118
142,681
162,303
224,970
275,851
684,217
707,348
763,733
826,341
1,055,924
1,363,693
1,483,065
1,597,715
1,607,452
1,700,008
1,700,0081,607,4521,597,7151,483,0651,363,6931,055,924826,341763,733707,348684,217275,851224,970162,303142,681142,118150,21463,0040
   Retained Earnings Total Equity000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000
   Capital Surplus 000000000000000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 
0
0
0
20,064
20,064
567
0
0
104
-407
-567
-621
-293
-500
370
-254
-444
-428
-428-444-254370-500-293-621-567-4071040056720,06420,064000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue821,682
Cost of Revenue-415,335
Gross Profit406,347406,347
 
Operating Income (+$)
Gross Profit406,347
Operating Expense-733,892
Operating Income87,790-327,545
 
Operating Expense (+$)
Research Development-
Selling General Administrative317,804
Selling And Marketing Expenses-
Operating Expense733,892317,804
 
Net Interest Income (+$)
Interest Income938
Interest Expense-52,149
Net Interest Income-51,211-51,211
 
Pretax Income (+$)
Operating Income87,790
Net Interest Income-51,211
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-256,727381,096
EBIT - interestExpense = 59,835
-279,490
-267,448
Interest Expense52,149
Earnings Before Interest and Taxes (ebit)111,984-204,578
Earnings Before Interest and Taxes (ebitda)-159,629
 
After tax Income (+$)
Income Before Tax-256,727
Tax Provision-40,107
Net Income From Continuing Ops-296,834-296,834
Net Income-319,597
Net Income Applicable To Common Shares-319,597
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses15,998
Total Other Income/Expenses Net-293,30651,211
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
CTW.BK
20 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of CTW.BK.

CTW.BK Daily Candlestick Chart
C76.SG
47 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of C76.SG.

C76.SG Daily Candlestick Chart
CSM.VN
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of CSM.VN.

CSM.VN Daily Candlestick Chart
VND.VN
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VND.VN.

VND.VN Daily Candlestick Chart
VNG.VN
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VNG.VN.

VNG.VN Daily Candlestick Chart
VCI.VN
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VCI.VN.

VCI.VN Daily Candlestick Chart
TPB.VN
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TPB.VN.

TPB.VN Daily Candlestick Chart
ST8.VN
1 hour ago

I found you a Death Cross on the daily chart of ST8.VN.

ST8.VN Daily Candlestick Chart
STB.VN
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of STB.VN.

STB.VN Daily Candlestick Chart
SJF.VN
1 hour ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SJF.VN.

SJF.VN Daily Candlestick Chart
SBT.VN
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SBT.VN.

SBT.VN Daily Candlestick Chart
VIX.VN
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VIX.VN.

VIX.VN Daily Candlestick Chart
POW.VN
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of POW.VN.

POW.VN Daily Candlestick Chart
NVL.VN
1 hour ago

I found you a Golden Cross on the daily chart of NVL.VN.

NVL.VN Daily Candlestick Chart
NTL.VN
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NTL.VN.

NTL.VN Daily Candlestick Chart
NKG.VN
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NKG.VN.

NKG.VN Daily Candlestick Chart
MWG.VN
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MWG.VN.

MWG.VN Daily Candlestick Chart
LDG.VN
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of LDG.VN.

LDG.VN Daily Candlestick Chart
LCG.VN
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of LCG.VN.

LCG.VN Daily Candlestick Chart
HUB.VN
1 hour ago

I found you a Falling Three Methods Candle Pattern on the daily chart of HUB.VN.

HUB.VN Daily Candlestick Chart
HT1.VN
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of HT1.VN.

HT1.VN Daily Candlestick Chart
HMC.VN
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of HMC.VN.

HMC.VN Daily Candlestick Chart
HCD.VN
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of HCD.VN.

HCD.VN Daily Candlestick Chart
GEX.VN
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GEX.VN.

GEX.VN Daily Candlestick Chart
FCM.VN
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of FCM.VN.

FCM.VN Daily Candlestick Chart